USPTO serial 86110651
BOSTON BIOMEDICAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 3, 2014
- Examiner
- MCBRIDE, THEODORE M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with BOSTON BIOMEDICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Dainippon Sumitomo Pharma Co., Ltd.
Osaka-shi, Osaka, JP
Other trademarks owned by Dainippon Sumitomo Pharma Co., Ltd.
Dainippon Sumitomo Pharma Co., Ltd.
Osaka-shi, Osaka, JP
Other trademarks owned by Dainippon Sumitomo Pharma Co., Ltd.
SUMITOMO DAINIPPON PHARMA CO., LTD.
OSAKA, JP
Other trademarks owned by SUMITOMO DAINIPPON PHARMA CO., LTD.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebeccah Gan
Rebeccah Gan WENDEROTH LLP1030 15th Street, NW Suite 400 EastWashington, D.C., DC 20005UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the central nervous system, peripheral nervous system, respiratory system, urogenital system, cardiovascular system, endocrine system, metabolic system, renal system, gastroenterologic system, ophthalmologic system, and dermatologic system; pharmaceutical preparations for the prevention and treatment of hematologic and oncologic disorders and diseases, psychiatric disorders and diseases, allergic disorders and diseases and disorders and diseases of the immune system, connective tissue and joints; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparation for use in chemotherapy | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Dainippon Sumitomo Pharma Co., Ltd.
- Other trademarks owned by Dainippon Sumitomo Pharma Co., Ltd.
- Other trademarks owned by SUMITOMO DAINIPPON PHARMA CO., LTD.
- Other trademarks in Class 005
- Similar marks named BOSTON BIOMEDICAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 8, 2021 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jun 3, 2019 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 4, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 4, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 3, 2014 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 3, 2014 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Apr 27, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 27, 2014 | ALIE | ASSIGNED TO LIE | — |
| Apr 7, 2014 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Apr 4, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 4, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 4, 2014 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 27, 2014 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Feb 27, 2014 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 21, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 15, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 8, 2013 | NWAP | NEW APPLICATION ENTERED | — |